| Product Code: ETC7644918 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antimicrobial Resistance Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Israel Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Israel Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Israel Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Israel Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Israel |
4.2.2 Growing awareness about the impact of antimicrobial resistance on public health |
4.2.3 Government initiatives to promote responsible use of antibiotics |
4.3 Market Restraints |
4.3.1 Lack of stringent regulations for antibiotic use |
4.3.2 Limited availability of new antibiotics and treatment options |
4.3.3 High cost associated with developing new antimicrobial drugs |
5 Israel Antimicrobial Resistance Market Trends |
6 Israel Antimicrobial Resistance Market, By Types |
6.1 Israel Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Israel Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Israel Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Israel Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Israel Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Israel Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Israel Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Israel Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Israel Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Israel Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Israel Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Israel Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Israel Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Israel Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Israel Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Israel Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Israel Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Israel Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Israel Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Israel Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Israel Antimicrobial Resistance Market Export to Major Countries |
7.2 Israel Antimicrobial Resistance Market Imports from Major Countries |
8 Israel Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.2 Number of reported cases of antibiotic-resistant infections in Israel |
8.3 Investment in research and development of novel antimicrobial agents |
9 Israel Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Israel Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Israel Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Israel Antimicrobial Resistance Market - Competitive Landscape |
10.1 Israel Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Israel Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here